Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic
December 2003
Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic.
Patients who don't take oral meds consistently can now get a shot every 2 weeks.
Risperdal Consta will come in 25, 37.5, and 50 mg vials.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote